$88.08
0.07[0.08%]
Last update: 9:19AM Get Real Time Here
BioNTech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioNTech using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | BNTX | Q1 | $2.20 | -$0.43 | — | — | $1.37B | $717.70M | — | — | Get Alert |
03/20/2024 | AM | BNTX | Q4 | $9.45 | $2.64 | $2.04 | — | $4.37B | $1.99B | $1.59B | -20.00% | Get Alert |
11/06/2023 | AM | BNTX | Q3 | $7.04 | $0.62 | $0.73 | 17.74% | $3.49B | $1.06B | $974.49M | -8.07% | Get Alert |
08/07/2023 | AM | BNTX | Q2 | $6.87 | -$0.75 | -$0.86 | -14.67% | $3.41B | $786.22M | $182.78M | -76.75% | Get Alert |
05/08/2023 | AM | BNTX | Q1 | $14.24 | $0.16 | $2.20 | 1275.00% | $6.37B | $1.60B | $1.37B | -14.31% | Get Alert |
03/27/2023 | AM | BNTX | Q4 | $12.18 | $8.61 | $9.45 | 9.76% | $5.53B | $4.25B | $4.37B | 2.75% | Get Alert |
11/07/2022 | AM | BNTX | Q3 | $12.35 | $4.42 | $7.04 | 59.28% | $6.09B | $2.03B | $3.49B | 71.87% | Get Alert |
08/08/2022 | AM | BNTX | Q2 | $12.97 | $7.36 | $6.87 | -6.66% | $6.39B | $4.09B | $3.41B | -16.70% | Get Alert |
05/09/2022 | AM | BNTX | Q1 | $5.29 | $9.71 | $15.97 | 64.47% | $2.47B | $4.59B | $7.16B | 55.90% | Get Alert |
03/30/2022 | AM | BNTX | Q4 | $1.87 | $8.19 | $13.93 | 70.09% | $411.87M | $4.31B | $6.33B | 46.82% | Get Alert |
11/09/2021 | AM | BNTX | Q3 | -$1.03 | $12.03 | $14.56 | 21.03% | $78.83M | $5.93B | $7.18B | 21.05% | Get Alert |
08/09/2021 | AM | BNTX | Q2 | -$0.42 | $8.91 | $12.97 | 45.57% | $45.99M | $3.84B | $6.39B | 66.54% | Get Alert |
05/10/2021 | AM | BNTX | Q1 | -$0.26 | $3.72 | $5.29 | 42.20% | $30.51M | $1.78B | $2.47B | 38.76% | Get Alert |
03/30/2021 | AM | BNTX | Q4 | -$0.28 | -$0.18 | $1.87 | 1138.89% | $31.08M | $224.87M | $411.87M | 83.16% | Get Alert |
11/10/2020 | AM | BNTX | Q3 | -$0.15 | -$0.42 | -$1.03 | -145.24% | $31.28M | $63.84M | $78.83M | 23.48% | Get Alert |
08/11/2020 | AM | BNTX | Q2 | — | -$0.28 | -$0.42 | -50.00% | — | $52.23M | $45.99M | -11.94% | Get Alert |
05/12/2020 | AM | BNTX | Q1 | — | -$0.27 | -$0.26 | 3.70% | — | $27.21M | $30.51M | 12.14% | Get Alert |
03/31/2020 | AM | BNTX | Q4 | — | -$0.14 | -$0.28 | -100.00% | — | $29.40M | $31.08M | 5.71% | Get Alert |
11/14/2019 | AM | BNTX | Q3 | — | — | -$0.15 | — | — | — | $31.28M | — | Get Alert |
BioNTech (BNTX) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 20, 2024 for Q4.
The Actual EPS was $2.05, which missed the estimate of $2.64.
The Actual Revenue was $1.6B, which missed the estimate of $2B.
Browse earnings estimates, EPS, and revenue on all stocks.